Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy

Not Applicable

Terminated

• Conditions: Hip Injuries
• Interventions: Drug: liposomal bupivacaine; Drug: Bupivacaine

• Registration Number: NCT01907191
• Lead Sponsor: Trinity Health Of New England

Brief Summary

This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours

Detailed Description

Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.

Study Timeline

• Study First Submitted: 2013-06-28
• Study Start: 2013-07
• Study First Submitted QC: 2013-07-18
• Study First Posted: 2013-07-24
• Primary Completion: 2019-01-30
• Study Completion: 2019-01-30
• Results First Submitted: 2022-05-27
• Results First Submitted QC: 2022-06-27
• Results First Posted: 2022-07-19
• Status Verified: 2022-08
• Last Update Submitted: 2022-08-12
• Last Update Posted: 2022-08-16

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

• Patients having hip arthroscopy

Exclusion Criteria

• History of neurologic disease, neuropathy, diabetes
• Allergy to local anesthetic solution
• Chronic use of narcotics
• Inability to give consent/cooperate with study
• History of previous hip arthroscopy on the ipsilateral side
• Pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Liposomal bupivacaine	liposomal bupivacaine	Ultrasound guided injection of liposomal bupivacaine for patients undergoing hip arthroscopy
Bupivacaine	Bupivacaine	Bupivacaine (around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy

Primary Outcome Measures

Name	Time	Method
Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)	Post Operative Day 1, 2 & 3	Consumption of 5mg Oxycontin tablets will be assessed on Post Operative Days 1, 2 \& 3.

Secondary Outcome Measures

Name	Time	Method
Pain Scores	Post Operative Day 1, 2 & 3	Analysis of pain scores (at rest and ambulation) during hospital stay. Measured on a 10 point pain scale (1 being no pain and 10 being worst pain imaginable)

Trial Locations

Locations (1)

Saint Francis Hospital and Medical Center; 🇺🇸 Hartford, Connecticut, United States